LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET 2019-2028

Lifesciences | Pharmaceuticals

LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET 2019-2028

Market by Device Type, Route of Administration, End-user, and Country | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton, the injectable drug delivery market in Latin America is expected to proliferate with a CAGR of 9.34% in the forecast period of 2019-2028.



Report scope can be customized per your requirements. Request For Customization

The countries evaluated in this market are:

           Brazil

           Mexico

           Rest of latin america

Latin America's injectable drug delivery market is majorly driven by the rise in the prevalence of chronic diseases and the enhanced pharmaceutical consumption owing to the adoption of drug delivery systems and technologies in the region. The increasing number of cases of cancer, diabetes, asthma, CVDs, etc., For instance, ProMexico, which is the Mexican federal government's trust fund, states that, owing to the increase in pharmaceutical consumption in the country in 2016-2017, the industry has shown revenue growth of $2,336 million. The body further states that, pharmaceutical consumption in the period between 2015 and 2020 will grow stupendously, registering 26,856 by 2020. These factors are favoring the injectable drug delivery market growth in the Latin American region.

Brazil's population has grown multifold in the past few decades. With the increase in life expectancy, there is a large number of older adults in the country. Individuals belonging to this population group are highly susceptible to various diseases. This has raised the demand for injectable drug delivery systems in the country, owing to the convenience of use provided by them. Further, according to an article, 600,000 new cases of cancer were reported in the country in 2018-2019. Injectable drug delivery technology is known to play a vital role in the treatment of cancer, and hence, the growing prevalence of cancer has enhanced the demand for these systems. All these factors are channeling the Brazilian injectable drug delivery market's growth.

Founded in 1970, Elcam Medical develops and manufactures disposable medical devices for the OEM market. Elcam Drug Delivery Devices is one of its four major business verticals. The company offers a wide range of drug delivery systems, including FlexiQ mMU and FlexiQ eMUP, thus contributing significantly to the global market. There are several opportunities for the organization to manufacture drug-injecting devices for severe central nervous system disorders.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANT

2.2.2.   THREAT OF SUBSTITUTE

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   INTENSITY OF COMPETITIVE RIVALRY

2.3. KEY INSIGHT

2.4. KEY BUYING CRITERIA

2.5. MARKET ATTRACTIVENESS INDEX

2.6. MARKET DRIVERS

2.6.1.   INCREASING GERIATRIC POPULATION

2.6.2.   TECHNOLOGICAL ADVANCEMENT

2.6.3.   GROWING OCCURRENCE OF AUTOIMMUNE DISEASES

2.7. MARKET RESTRAINT

2.7.1.   HIGH MANUFACTURING COST OF INJECTABLE DRUG DELIVERY SYSTEMS

2.8. MARKET OPPORTUNITY

2.8.1.   DEVELOPMENT OF BETTER INJECTABLE SYSTEMS

2.8.2.   INCREASE IN HEALTHCARE EXPENDITURE

2.9. MARKET CHALLENGES

2.9.1.   DEVELOPMENTS IN ALTERNATE DRUG DELIVERY SYSTEMS

2.9.2.   STRINGENT REGULATIONS

3.    INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY DEVICE TYPE

3.1. PEN INJECTOR

3.2. AUTO-INJECTOR

3.3. NEEDLE-FREE INJECTOR

3.4. PREFILLED SYRINGE

4.    INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION

4.1. SUBCUTANEOUS

4.2. INTRAMUSCULAR

4.3. INTRAVENOUS (IV)

4.4. OTHER ROUTE OF ADMINISTRATION

5.    INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY END-USER

5.1. CLINICS/ PHYSICIAN OFFICES

5.2. AMBULATORY CARE

5.3. HOSPITAL

5.4. HOME-BASED

5.5. OTHER END-USERS

6.    INJECTABLE DRUG DELIVERY MARKET – LATIN AMERICA

6.1. COUNTRY ANALYSIS

6.1.1.   BRAZIL

6.1.2.   MEXICO

6.1.3.   REST OF LATIN AMERICA

7.    COMPANY PROFILES

7.1. BAXTER INTERNATIONAL INC

7.2. BECTON DICKINSON AND COMPANY (BD)

7.3. ELCAM MEDICAL

7.4. ELI LILLY AND COMPANY

7.5. GERRESHEIMER

7.6. INJEX

7.7. NOVARTIS AG

7.8. NOVO NORDISK A/S

7.9. PFIZER INC

7.10.  SANOFI SA

7.11.  SCHOTT AG

7.12. TERUMO CORPORATION

7.13.  TEVA PHARMACEUTICALS

7.14.   WEST PHARMACEUTICALS

7.15.  YPSOMED HOLDING AG

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE  1       LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY REGION, 2019-2028 ($ MILLION)

TABLE  2       LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2028 ($ MILLION)

TABLE  3       DIFFERENT TYPES OF INSULIN PEN INJECTORS

TABLE  4       MARKETED NEEDLE-FREE INJECTORS PRODUCTS

TABLE  5       LYOPHILIZED DRUGS WHICH ARE USED IN PREFILLED SYRINGE

TABLE  6       LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 ($ MILLION)

TABLE  7       LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE  8       LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)   

List of Figures

FIGURE  1     LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  2     KEY BUYING IMPACT ANALYSIS

FIGURE  3     LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY PEN INJECTOR, 2019-2028 ($ MILLION)

FIGURE  4     LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY AUTO-INJECTOR, 2019-2028 ($ MILLION)

FIGURE  5     LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY NEEDLE-FREE INJECTOR, 2019-2028 ($ MILLION)

FIGURE  6     LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY PREFILLED, 2019-2028 ($ MILLION)

FIGURE  7     LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY SUBCUTANEOUS, 2019-2028 ($ MILLION)

FIGURE  8     LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY INTRAMUSCULAR, 2019-2028 ($ MILLION)

FIGURE  9     LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY INTRAVENOUS, 2019-2028 ($ MILLION)

FIGURE  10  LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY OTHER ROUTE OF ADMINISTRATION, 2019-2028 ($ MILLION)

FIGURE  11  LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY CLINICS/PHYSICIAN OFFICES, 2019-2028 ($ MILLION)

FIGURE  12  LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY AMBULATORY CARE, 2019-2028 ($ MILLION)

FIGURE  13  LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY HOSPITAL, 2019-2028 ($ MILLION)

FIGURE  14  LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY HOME-BASED, 2019-2028 ($ MILLION)

FIGURE  15  LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY OTHER END-USER, 2019-2028 ($ MILLION)

FIGURE  16  BRAZIL INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  17  MEXICO INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  18  REST OF LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;